| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 22 |
| 1 | ERLOTINIB HYDROCHLORIDE | 12 |
| 2 | CELECOXIB | 11 |
| 3 | MYCOPHENOLATE MOFETIL | 9 |
| 4 | CIDOFOVIR ANHYDROUS | 8 |
| 5 | ERLOTINIB | 8 |
| 6 | TACROLIMUS | 8 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 8 | TACROLIMUS OINTMENT 0.1% | 8 |
| 9 | HYDROXYCHLOROQUINE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 8 | 0.0055 |
| 1 | ERLOTINIB HYDROCHLORIDE | 12 | 0.0010 |
| 2 | BEVACIZUMAB-AWWB | 1 | 0.0002 |
| 3 | BICALUTAMIDE | 3 | 0.0002 |
| 4 | BEVACIZUMAB | 22 | 0.0002 |
| 5 | TIGECYCLINE | 1 | 0.0002 |
| 6 | CLARITHROMYCIN | 3 | 0.0001 |
| 7 | CELECOXIB | 11 | 0.0001 |
| 8 | MYCOPHENOLATE MOFETIL | 9 | 0.0001 |
| 9 | TACROLIMUS OINTMENT 0.1% | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 22 | 0.0001 |
| 2 | Macrolide Antimicrobial [EPC] | 3 | 0.0001 |
| 3 | Androgen Receptor Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 5 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 3 | 0.0000 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Anti-IgE [EPC] | 1 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |